KALA BIO, Inc.
USD1.78
-0.31 (-14.83%)
CEO
Avi Minkowitz
IPO Date
2017-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.08
Prev. Close
$2.09
Day Low
$1.75
Day High
$2.08
52W Low
$1.75
52W High
$1030.00
Market Cap
$0.04B
Volume
0.12M
| -49.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -562.4% | -75.4% | 4.84 | 6.33 | -20.2 |
| 31 Dec 2022 | FY | 34.2% | -1151.6% | -236.2% | -51.6% | 2.26 | 3.35 | -64.7 |
| 31 Dec 2021 | FY | 63.5% | -1268.7% | -848.6% | -102.3% | 4.77 | 3.32 | -27.7 |
| 31 Dec 2020 | FY | 50.1% | -1639.8% | -104.3% | -47.1% | 1.01 | 7.71 | -170.2 |
| 31 Dec 2019 | FY | 53.1% | -1553.3% | -317.8% | -61.1% | 3.41 | 4.26 | -66.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -63.6% | -30.2% | 0.95 | 10.41 | -98.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -47.1% | -36.3% | 0.21 | 7.97 | -466.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 37.8% | -71.6% | -0.11 | 8.23 | -481.8 |
| 82.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 87.3% | -30.2% | -3.58 | 0.75 | -17.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 347.9% | -30.9% | -9.34 | 2.10 | -34.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -156.7% | -18.5% | 5.67 | 1.99 | -50.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -66.3% | -14.7% | 2.62 | 3.11 | -49.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -130.5% | -16.5% | 5.40 | 2.15 | -36.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -69.8% | -15.5% | 2.68 | 3.07 | -27.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -177.3% | -22.3% | 5.49 | 4.22 | -23.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -115.0% | -15.4% | 4.84 | 6.33 | -27.5 |